Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection

HIV-1 在传播和全身感染过程中的先天免疫监视

基本信息

项目摘要

Project Summary Innate immune responses represent one of the first and most potent lines of defense against infection. Importance of this surveillance network is underscored by the numerous mechanisms that pathogens have evolved to counteract and evade these responses. The success of the immediate innate immune response relies on the recognition of conserved structures, termed pathogen associated molecular patterns (PAMPs), commonly present in microbes but not in the host. Pattern recognition receptors (PRRs) act as microbial sensors for the host. The sensing of PAMPs by host PRRs initiate the induction of several intracellular signaling events, triggering the expression of cytokines and interferons, which can govern potent restrictors of pathogen infection. In this application, we propose to pursue the hypothesis that a robust innate immune recognition and response to HIV-1 exposure, likely elicited from abortive infection of myeloid cells, rises from the activation of key pattern recognition receptor (PRR) pathways and results in a localized antiviral environment that markedly decreases the likelihood of CD4+ T cell infection and subsequent spread of infection, both in the mucosa and during peripheral infection. The cGAS cytoplasmic DNA sensing pathway, which is particularly active in myeloid cells, has recently been identified as a key sensor for reverse transcribed HIV-1 DNA. Activation of this and potentially other PRR-governed pathways promote the secretion of interferons (IFNs) leading to the transcription of hundreds of interferon-stimulated genes (ISGs), some of which contribute to suppression of HIV-1 replication. Recently, we have reported the identification PQBP1 as a critical component in the recognition of early HIV-1 nucleic acid products required for activation of the cGAS DNA sensing pathway, resulting IFN induction in HIV-infected myeloid cells. Here, we propose to investigate in more detail the regulation of this novel sensing circuit, including understanding the features and accessibility of the HIV-1 PAMP, its downstream regulation, and its impact in HIV-1 transmission. A better understanding of the innate response circuitry that senses HIV-1 infection is likely to enable the development of novel therapeutic interventions against systemic HIV-1 infection, and the illumination of the molecular basis of a protective mucosal innate response to HIV-1 will be critical in next generation vaccine and adjuvant design.
项目摘要 先天免疫反应是抵抗感染的第一道也是最有效的防线之一。 病原体具有的多种机制强调了这一监测网络的重要性 进化来抵消和逃避这些反应。即刻先天免疫反应的成功 依赖于保守结构的识别,称为病原体相关分子模式(PAMP), 通常存在于微生物中,但不存在于宿主中。模式识别受体(PRRs)作为微生物 主机的传感器。宿主PRR对PAMPs的感应启动了几种细胞内的诱导, 信号事件,触发细胞因子和干扰素的表达,这可以控制有效的限制因子, 病原体感染在本申请中,我们提出了一个假设,即一个强大的先天免疫系统, 对HIV-1暴露的识别和反应,可能是由骨髓细胞的流产感染引起的, 关键模式识别受体(PRR)途径的激活,并导致局部抗病毒 环境,显着降低CD 4 + T细胞感染的可能性和随后的传播, 感染,无论是在粘膜和外周感染。cGAS细胞质DNA传感途径, 在骨髓细胞中特别活跃,最近被鉴定为逆转录酶的关键传感器。 HIV-1 DNA这种和潜在的其他PRR调控途径的激活促进了 干扰素(IFN)导致数百个干扰素刺激基因(ISG)的转录,其中一些 有助于抑制HIV-1的复制。最近,我们报道了鉴定PQBP 1作为一个关键的 识别cGAS DNA激活所需的早期HIV-1核酸产物的组分 感应途径,导致HIV感染的骨髓细胞中的IFN诱导。在这里,我们建议调查更多 详细介绍了这种新型传感电路的调节,包括了解的特点和可访问性, HIV-1 PAMP,其下游调节及其在HIV-1传播中的影响。更好地理解 感知HIV-1感染的先天反应回路可能使新的治疗药物的开发成为可能。 针对系统性HIV-1感染的干预措施,以及对保护性HIV-1感染的分子基础的阐明, 粘膜对HIV-1的先天反应在下一代疫苗和佐剂设计中将至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUMIT K CHANDA其他文献

SUMIT K CHANDA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUMIT K CHANDA', 18)}}的其他基金

Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.
HIV-1 先天免疫感应的决定因素及其在塑造淋巴环境中的作用。
  • 批准号:
    10712594
  • 财政年份:
    2023
  • 资助金额:
    $ 91.01万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10514318
  • 财政年份:
    2022
  • 资助金额:
    $ 91.01万
  • 项目类别:
Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)
抗病毒药物中心
  • 批准号:
    10514317
  • 财政年份:
    2022
  • 资助金额:
    $ 91.01万
  • 项目类别:
Reversing Immune Dysfunction for HIV-1 Eradication
逆转免疫功能障碍以根除 HIV-1
  • 批准号:
    10469447
  • 财政年份:
    2021
  • 资助金额:
    $ 91.01万
  • 项目类别:
Reversing Immune Dysfunction for HIV-1 Eradication
逆转免疫功能障碍以根除 HIV-1
  • 批准号:
    10313784
  • 财政年份:
    2021
  • 资助金额:
    $ 91.01万
  • 项目类别:
Reversing Immune Dysfunction for HIV-1 Eradication
逆转免疫功能障碍以根除 HIV-1
  • 批准号:
    10540209
  • 财政年份:
    2021
  • 资助金额:
    $ 91.01万
  • 项目类别:
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo
项目 2 - 调节流感复制和宿主离体反应的宿主病毒网络
  • 批准号:
    10080715
  • 财政年份:
    2018
  • 资助金额:
    $ 91.01万
  • 项目类别:
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
用于治疗实体瘤的小分子树突状细胞免疫增强剂的早期开发
  • 批准号:
    10180915
  • 财政年份:
    2018
  • 资助金额:
    $ 91.01万
  • 项目类别:
A Novel Conformation of the ZIKV Protease Provides a Unique 3D Scaffold for Discovering Allosteric Protease Inhibitors as Direct Anti-virals, via HT and Virtual Screening, and Protein Engineering
ZIKV 蛋白酶的新颖构象为通过 HT 和虚拟筛选以及蛋白质工程发现变构蛋白酶抑制剂作为直接抗病毒药物提供了独特的 3D 支架
  • 批准号:
    9757689
  • 财政年份:
    2018
  • 资助金额:
    $ 91.01万
  • 项目类别:
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo
项目 2 - 调节流感复制和宿主离体反应的宿主病毒网络
  • 批准号:
    10322693
  • 财政年份:
    2018
  • 资助金额:
    $ 91.01万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 91.01万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了